Cyberounds Logo
November 17, 2019 | LOGIN | REGISTER | HELP | 

According to the late night television host Stephen Colbert, Americans should relax and try not to get high blood pressure from the political environment because now we won’t be able to afford the treatment. If only it were so simple.

There are many barriers to adequate blood pressure control. Some people are simply not firmly diagnosed. Others fail to keep up with regular treatment for the condition. Still others do not adhere to medication guidelines. A lack of insurance and high out of pocket costs play into these barriers to seeking care for hypertension.

Politicians tend not to listen to health care providers about health care issues, at least not until it personally affects them, so meanwhile what can we offer our patients with high blood pressure?

Some answers can be found in our current Cyberounds®. Please join Aditya Khetan, M.B.B.S., Cardiology Fellow, Harrington Heart & Vascular Institute; Richard A Josephson, M.S., M.D., Professor of Medicine, Case Western Reserve University School of Medicine and Director Cardiac Intensive Care and Director Cardiovascular and Pulmonary Rehabilitation, Harrington Heart & Vascular Institute; and Sri Krishna Madan Mohan M.B.B.S., Chief Quality Officer, Harrington Heart & Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, as they present Current Management of Hypertension

This activity has been approved for 1.0 AMA PRA Category 1 Credit™.

If it can happen to an elite athlete like Serena Williams, it can happen to anyone!

Indeed, it causes between 500,000 and 600,000 cases and an estimated 50,000 to 200,000 deaths in the United States every year.

Acute pulmonary embolism (PE) represents the most dangerous end of the spectrum of venous thromboembolic disease, which also includes deep venous thrombosis.

What is PE's epidemiology? Its risk factors? And, most importantly, how do we diagnose PE and treat it?

Please join Keith Albrektson, M.D., Resident, Department of Medicine, Ben Alencherry, M.D., Chief Resident, Department of Medicine and Jihane Faress, M.D., Assistant Professor of Medicine, University Hospitals, Louis Stokes Cleveland VA Medical Center and Case Western Reserve School of Medicine, as they bring you a 2019 update of Harvard Associate Professor of Surgery Christopher Kabrhel's Pulmonary Embolism

This activity has been approved for 1.0 AMA PRA Category 1 Credit™.

The management of type 1 diabetes continues to be difficult.

And, making matters worse, not only does TIDM's prevalence keep rising, but the price of insulin, the mainstay of treatment, has gone up dramatically, doubling between 2013-2016, according to the Healthcare Cost Institute.

Yet, in the face of this challenging environment, the practitioner has available new and modified insulin options for the TIDM patient.

Please join Kristen Welch, M.D., Chief Resident, Department of Medicine, Ben Alencherry, M.D., Chief Resident, Department of Medicine and Nadine El Asmar, M.D., Assistant Professor of Medicine, University Hospitals, Louis Stokes Cleveland VA Medical Center and Case Western Reserve School of Medicine, as they bring you a 2019 update of Einstein Clinical Professor Joel Zonszein's The Treatment and Management of Type 1 Diabetes Mellitus

This FREE activity has been approved for 1.0 AMA PRA Category 1 Credit™

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide. And despite improvements in treatment, patients continue to have a dismal prognosis, with 5-year survival rates of only 18%.

Though hepatitis B and cirrhosis are known risk factors, some of the awful HCC statistics are related to under-recognition of at-risk patients, as well as underuse of available treatments. But with new therapies on the horizon, the opportunity to customize clinical management offers more than a glimmer of hope for HCC patients.

Please join Brian C. Davis, M.D., Resident Physician, and Amit G. Singal, M.D., M.S., Associate Professor, Medical Director of Liver Tumor Program, Department of Internal Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, TX, as they discuss the Treatment of Hepatocellular Carcinoma.

This activity has been approved for 1.0 AMA PRA Category 1 Credit™.

Donald Trump, as well as several 2020 candidates for president of the United States, are over 70 years old. While the political positions among the candidates are surely different, they all share one common proclivity -- they are at risk of breaking down physically.

Osteoporosis is responsible for an estimated two million fractures per year, yet nearly 80% of older Americans who suffer fractures are not tested or treated for osteoporosis.

Please join Jessica Shu, M.D., Chief Resident, and Ahman Rajpal, M.D., Assistant Professor, Department of Medicine, Division of Clinical and Molecular Endocrinology, University Hospitals Cleveland Medical Center, Case Western Reserve University and Louis Stokes Cleveland VA Medical Center, and Ben Alencherry, M.D., Cardiovascular Fellow, Cleveland Clinic, Cleveland, OH., as they bring you an update of Professor Robert Pignolo’s Osteoporosis: Treatment and Management.

This activity has been approved for 1.0 AMA PRA Category 1 Credit™.

Companies proudly offer wellness programs to their employees, which always sounds like a great benefit. The guiding belief is that a physically and mentally fit employee will not only be healthier but will also be more productive. But the reality, however, is somewhat more problematic.

Especially concerning in the Age of Obamacare is who really pays for the program — the employer or the employees?

Do wellness programs compromise employee privacy and the confidentiality of medical information? Do they disrupt the doctor-patient relationship of trust?

And do they unfairly penalize those with conditions — weight loss is one example — that most people cannot substantially change even with the best of intentions?

Please join Maxwell J. Mehlman, J.D., Distinguished University Professor, Arthur E. Petersilge Professor of Law and Director of the Law-Medicine Center, Case Western Reserve University School of Law, and Professor of Bioethics, Case Western Reserve University School of Medicine, as he discusses Corporate Wellness Programs: Pros and Cons.

This activity has been approved for 1.0 AMA PRA Category 1 Credit™.

They are a self-sustaining source of energy. They are autonomous and omnipresent.

Unlike most energy producers, they don't use fossil fuels or uranium. So, in no way, do they contribute to global warming.

Every eukaryotic organism, from amoeba to human beings, depends on their continued efficient performance. But they are not perfect. Indeed, their dysfunction is the source of the largest group of metabolic diseases.

Please join Claus Desler, Ph.D., Assistant Professor, and Lene Juel Rasmussen, Ph.D., Professor and Managing Director, Center for Healthy Aging, Department of Molecular and Cellular Medicine, University of Copenhagen, Denmark, as they discuss Mitochondria in Health and Disease.

This activity has been approved for 1.0 AMA PRA Category 1 Credit™.

Finally, some seriously good news on cancer treatment — specifically, acute myelocytic leukemia or AML.

Two drug candidates for AML are expected to gain FDA approval in 2017. In randomized phase 3 trials both have offered significant overall survival time (OS) benefit. They will be the first drugs approved for AML in over a decade.

Please join Mary-Elizabeth Percival, M.D., M.S., Assistant Professor of Medicine, University of Washington School of Medicine, and Assistant Member, Fred Hutchinson Cancer Research Center, and Roland B. Walter, M.D., Ph.D., M.S., Associate Professor of Medicine and Associate Member, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., as they present Emerging Treatments In Acute Myeloid Leukemia (AML).

This activity has been approved for 1.0 AMA PRA Category 1 Credit™.

For many adults, and increasingly for children, overeating is problematic for our health and well being.

Indeed, approximately two-thirds of Americans are now classified as overweight or obese.

So the issue becomes for everyone -- patients and their providers -- what can be done going forward to reduce the excess weight? Specifically, are diets that emphasize low carbs or those that are high protein more likely to lead to weight loss?

Please join John Merriman, M.D., Chief Resident, Ahman Rajpal, M.D., Assistant Professor, Department of Medicine, Division of Clinical and Molecular Endocrinology, University Hospitals Cleveland Medical Center, Case Western Reserve University and Louis Stokes Cleveland VA Medical Center, and Ben Alencherry, M.D., Cardiovascular Fellow, Cleveland Clinic, Cleveland, OH., as they bring you an update of Professor Edward Saltzman’s Low Carb vs. High Protein Diets.

This activity has been approved for 1.0 AMA PRA Category 1 Credit™.

It's more likely to affect women and African Americans. And, globally, it's the second leading cause of blindness, afflicting more than 60 million people.

We don't know for certain what causes open angle glaucoma (OAG), but luckily, there are some promising new treatments on the horizon.

Please join Yang Sun, M.D., Ph.D., Associate Professor of Ophthalmology, Stanford University School of Medicine, Palo Alto, CA, and Enoch Kassa, M.D., Resident in Ophthalmology, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, IN, as they discuss emerging treatments and procedures which may dramatically reduce the disease burden of Open Angle Glaucoma. This activity has been approved for 1.0 AMA PRA Category 1 Credit.™

While schizophrenia’s positive symptoms such as hallucinations and delusions are largely responsive to antipsychotic medication, negative symptoms like anhedonia and cognitive symptoms (memory and attentional deficits) are challenging, constituting a major unmet therapeutic need.

Cognitive symptoms, in particular, have been the focus of substantial on-going clinical and preclinical research because they are highly predictive of long-term functional outcome in patients.

And now emerging research suggests that cholinergic and dopaminergic modulation of the prefrontal cortex may usher in the development of new therapeutics.

Please join Sarah Canetta, Ph.D., Associate Research Scientist, and Christoph Kellendronk, Ph.D., Assistant Professor of Pharmacology (in Psychiatry), Departments of Psychiatry & Pharmacology, Columbia University, and the Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, as they discuss the Molecular Mechanisms of Cognitive Deficits in Schizophrenia

This eCME activity has been approved for 1.0 AMA PRA Category 1 Credit™

In the ten years since we first presented Keith Woeltje’s Cyberounds on Infection Control much has changed. Though the incidence of healthcare-associated infections (HAIs) has decreased, infective agents have not disappeared and continue to pose a risk. Indeed, in an age of remarkable new surgical transplants, infection control is especially critical to the well-being of these and other immunocompromised patients.

E. Chandler Church, M.D., M. Sc., and Keith Armitage, M.D., Resident, Department of Mediicine and Professor of Medicine, Division of Infectious Diseases & HIV Medicine, University Hospitals Cleveland Medical Center and Case Western Reserve School of Medicine, provide a 2019 update to Keith Woeltje’s Infection Control.

This FREE activity has been approved for 1.0 AMA PRA Category 1 Credit™.

We don’t need a public opinion poll to certify that it's becoming a disease of adult medicine.

Though many can still live normal lives and remarkable progress has been made in acute and chronic management, especially with target-specific therapy, cystic fibrosis continues to pose tremendous treatment burden to patients, their families and their caregivers.

Please join Arindam Singha, M.D., Fellow, Pulmonary & Critical Care Medicine and Stephen E. Kirkby, M.D., Associate Professor, Pulmonary & Critical Care Medicine, The Ohio State University Medical Center and Nationwide Children’s Hospital, Columbus, OH, as they present Cystic Fibrosis -- No Longer Just a Disease of Pediatric Medicine.

This activity has been approved for 1.0 AMA PRA Category 1 Credit™.

Their low incidence makes it difficult to run clinical trials on potential new treatments. That’s a problem because these diseases are often debilitating and new therapies are urgently needed.

Please join Siamak Moghadam-Kia, M.D., Assistant Professor, Rohit Aggarwal, M.D., Associate Professor and Chester V. Oddis, M.D., Professor, Myositis Center and Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, as they present Treating Idiopathic Inflammatory Myopathy. This activity has been approved for 1.0 AMA PRA Category 1 Credit.™

Reproductive rights are a contentious subject. Regardless of your personal beliefs, there are things you need to know as a healthcare professional about a woman’s right to be in charge of her own body in order to fully inform your patients.

Nada L. Stotland, M.D., M.P.H., is Professor of Psychiatry at Rush Medical College, a past president of the American Psychiatric Association, and the author of several peer-reviewed books on reproductive rights. Please join her for this special Cyberounds® Women’s Health, Caring for Women and Their Families: The Essential Role of Reproductive Rights.

This activity has been approved for 1.0 AMA PRA Category 1 Credit™.

Myocardial infarction (MI) remains a leading cause of morbidity and death. Progress has been made in both primary and secondary prevention, but care of the post-MI patient is fraught with challenges.

Patients are often very anxious about their chances of another MI. They are more aware of chest symptoms, and may be depressed and afraid to resume their daily activities, including having sex.

What should the clinician do and recommend for their patients post-MI?

Authors Richard Josephson, M.S., M.D., Professor of Medicine, Case Western Reserve University School of Medicine. Director Cardiac Intensive Care Unit and Director Cardiovascular & Pulmonary Rehabilitation at Harrington Heart & Vascular Institute, and Sri K. Madan Mohan, M.D., Assistant Professor of Medicine, Chief Quality Officer and Program Director, Harrington Heart & Vascular Institute, Case Western University School of Medicine, Cleveland, OH., present Management of the Post-Myocardial Infarction Patient.

This activity has been approved for 1.0 AMA PRA Category 1 Credit™



MERring
Member of the Medical Education Ring
Linking medical education web sites worldwide



[Prev | Next | Skip One | Next 5 | List all | Random]